CDEK
← All organizations

Collegium Pharmaceutical, Inc.

For profitWebsite ↗

Also known as: Collegium Pharmaceutical, Inc. | COLLEGIUM PHARM INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Aug 1, 2012

First marketed drug

Nov 20, 2008

Last known activity

Sep 13, 2024

Timeline

2000s

  1. Jan 1, 2002

    Collegium Pharmaceutical, Inc.— Founded

  2. Nov 20, 2008

    tapentadol— NDA Secondary Org

  3. Nov 20, 2008

    tapentadol— Marketing Organization

2020s

  1. Feb 14, 2022

    BioDelivery Sciences International— Acquired

Drugs by trial phase (7 distinct, 21 trials)

Phase 4 (0 own, 1 via acquisition)

Phase 3 (1 own, 3 via acquisition)

Phase 2 (0 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Stoughton, MA, US Jan 1, 2002
Last known activity
Sep 13, 2024